Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-004785-98Phase 4Terminated
Phase 4, open-label, single-arm trial of hepatitis B vaccine recombinant in hepatitis B (HBV), sponsored by University of Oxford. Started Jan 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-004785-98.